The Reduction Of Eye Fatigue Improves Vision In Older Subjects
[2009/08/05] [Fuji Chemical Industry Co.]
a current study performed at the Kajita Clinic in Tokyo, Japan and published in March, 2009 has shown significant improvement in the ability to focus on nearby objects in older subjects (mean age of 53.9 ± 5.1 years) with supplementation of the antioxidant, astaxanthin.
|
New Study: Mirtogenol(TM) Lowers High Intraocular Hypertension
[2008/07/27] [Horphag Research Ltd. ]
New research published in the July issue of Molecular Vision demonstrates that natural supplement Mirtogenol(TM), a combination of standardized bilberry extract Mirtoselect® and French maritime pine bark extract Pycnogenol®, lowers high intraocular pressure (IOP), which significantly reduces the likelihood of developing glaucoma.
|
Fatty acids beneficial in treatment for dry eye syndrome
[2008/02/12] [Massachusetts Eye and Ear Infirmary (MEEI)]
Research conducted at the Schepens Eye Research Institute have found for the first time that topical drop application of alpha-linolenic acid (ALA) led to a significant decrease in clinical signs of dry eye syndrome (DES) in animal models.
|
Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease
[2007/05/15] [JAMA/Archives journals]
Two reports in the May issue of Archives of Ophthalmology indicate that Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease.
|
Two new studies boost evidence for the bioavailability and efficacy of Xangold(R) natural lutein esters
[2007/05/09] [Cognis Nutrition & Health ]
In his presentation at the Vitafoods International Supplier Seminar Theatre today (Wednesday, May 9), Holger Becker, Ph.D., cited two new studies which strengthen existing scientific evidence on the bioavailability and efficacy of Xangoldâ natural lutein esters.
|
New study shows that a daily supplement of 12 mg lutein from Xangold(R) natural lutein esters increases macular pigment density in adults with early-stage AMD
[2007/05/08] [Cognis]
Study published in the April edition of Experimental Eye Research involved 108 adults who received a daily supplement containing antioxidants - including 12 mg lutein from Xangold(R) lutein esters - for six months and a contro, groupo who recevied no supplements. Results in the intervention group showed substantial increases in blood levels of lutein and a statistically significant average increase of 16% in macular pigment density.
|
Researchers study supplements to limit damage from macular degeneration
[2007/03/15] [Washington University School of Medicine]
A team of investigators at Washington University School of Medicine in St. Louis and other centers around the United States is evaluating dietary supplements to determine if they can prevent some of the damage from age-related macular degeneration. Some patients also will receive certain omega-3 fatty acids that are contained in fish oils, and others will take supplements containing either lutein and zeaxanthin that normally are made in the retina.
|
New Study Shows Zeaxanthin and Lutein Supplements Imrove Night Vision and Visual Performance
[2006/10/23] [DSM Nutritional Products]
Study appearing in Ophthalmic and Physiological Optics, The Journal of the College of Optometrists suggests that night vision can be improved by supplementing a diet with lutein and OPTISHARP(TM) brand zeaxanthin.
|
New Nationwide Study Will Evaluate Effect of Antioxidants and Fish Oil on Progression of Age-Related Macular Degeneration (AMD)
[2006/10/12] [The National Institutes of Health (NIH)]
The National Institutes of Health (NIH) announces a nationwide study, Age-Related Eye Disease Study 2 (AREDS2), to see if a modified combination of vitamins, minerals, and fish oil can further slow the progression of vision loss from AMD, the leading cause of vision loss in the United States for people over age 60.
|
Study: Astaxanthin Prevents the Onset Of Asthenopia
[2006/09/25] [Fuji Health Science, Inc.]
Company announces the publication of the ninth clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
|
Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
[2006/07/24] [DHA-EPA Omega-3 Institute]
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
|
Web Site Detailing Zeaxanthin Science Adds New Pola Group Study
[2006/06/27] [Chrysantis]
Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group.
|
Chrysantis(TM), Inc. Responds to Lutein, Zeaxanthin Study
[2005/07/15] [Chrysantis(TM), Inc]
Company reponds to interpretation of study results published in the Journal of Nutrition (135:1763-1769, July 2005) regarding lutein and zeaxanthin.
|
New Study Demonstrates That Xangold® Natural Lutein Ester Supplements May Benefit Those With Early Stage Macular Degeneration
[2004/07/27] [Cognis NUtrition and Health]
|